Registered number
12990573
Developer Genome Ltd
Filleted Accounts
30 November 2024

Developer Genome Ltd
Registered number: | 12990573
Balance Sheet
as at 30 November 2024
|  |  |  | 2024 |  |  | 2023
£ | £
Called up share capital not paid |  |  |  | - |  |  | -
Fixed assets |  |  |  | - |  |  | -
Current assets |  |  | 522 |  |  | 323
Prepayments and accrued income |  |  | - |  |  | -
|  |  | 522 |  |  | 323
Creditors: amounts falling due within one year |  |  | (375) |  |  | (1,365)
Net current assets/(liabilities) |  |  |  | 147 |  |  | (1,042)
Total assets less current liabilities |  |  |  | 147 |  |  | (1,042)
Creditors: amounts falling due after more than one year |  |  |  | - |  |  | -
Provisions for liabilities |  |  |  | - |  |  | -
Accruals and deferred income |  |  |  | (144) |  |  | -
Net assets/(liabilities) |  |  |  | 3 |  |  | (1,042)
Capital and reserves |  |  |  | 3 |  |  | (1,042)
Number | Number
Average number of employees |  |  |  | 0 |  |  | 0
[Loans to directors, guarantees made by the company on behalf of directors]
[Capital commitments, pension commitments, other financial commitments and contingent liabilities]
The company is a private company limited by shares and incorporated in England. Its registered office is 71-75 Shelton Street, London, Greater London, United Kingdom, WC2H 9JQ.
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro entity provisions of the Companies Act 2006 and FRS 105, The Financial Reporting Standard applicable to the Micro-entities Regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
V Bondarenko
Director
Approved by the board on 7 November 2025

Developer Genome Ltd 12990573 false 2023-12-01 2024-11-30 2024-11-30 VT Final Accounts April 2025 V Bondarenko No description of principal activity 12990573 2022-12-01 2023-11-30 12990573 core:WithinOneYear 2023-11-30 12990573 core:AfterOneYear 2023-11-30 12990573 2023-12-01 2024-11-30 12990573 bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 12990573 bus:AuditExemptWithAccountantsReport 2023-12-01 2024-11-30 12990573 countries:England 2023-12-01 2024-11-30 12990573 bus:Director40 2023-12-01 2024-11-30 12990573 bus:Micro-entities 2023-12-01 2024-11-30 12990573 bus:FilletedAccounts 2023-12-01 2024-11-30 12990573 2024-11-30 12990573 core:WithinOneYear 2024-11-30 12990573 core:AfterOneYear 2024-11-30 12990573 2023-11-30 iso4217:GBP xbrli:pure